Collecting liver samples to build models for liver cancer and liver disease research
Collects blood and biopsy samples from adults with liver disease or liver cancer for research.
Plain-language title generated from the registry record
Registry title: "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
Key facts
- Where
- Strasbourg, FranceSee the site
Where in France
- PU-PH, Directeur de l'UMR_S1110 Unité Inserm d'affiliation : UMR_S1110Strasbourg, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Institut National de la Santé Et de la Recherche Médicale, France
- Trial code
- NCT04690972
- Record updated
- 22 October 2026
- Original description
Development of preclinical translational models for chronic liver tumors and diseases study, such as spheroids cultured in autologous medium and murine xenograft models to test the efficacy of new therapeutic strategies.Read full original descriptionShow less
"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
Development of preclinical translational models for chronic liver tumors and diseases study, such as spheroids cultured in autologous medium and murine xenograft models to test the efficacy of new therapeutic strategies.
Inclusion: Patients; diagnosed with chronic liver disease (viral or not); diagnosed with at least one liver nodule for which a biopsy is planned as part of the care; for hepatobiliary surgery planned as part of care; for locoregional treatment for HCC is indicated; Patients able to receive and understand information relating to the study and give their written informed consent; Patients affiliated to the French social security system.
Exclusion: Minor patients; Patients under legal protection,; Patients subject to legal protection or unable to express their consent,; Patients in a situation of social fragility,; Pregnant or breastfeeding woman,; No signing of informed consent.